Clinical Trials in Philadelphia

Showing 11561-11580 of 20,904 trials

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

NCT01055067

This is a multicenter, single-arm study for safety and efficacy.

Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)

Daiichi Sankyo27 participantsStarted Feb 2010

Los Angeles, California, United States • Orlando, Florida, United States • Indianapolis, Indiana, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

NCT02527265

Primary Objective: -To assess the safety and tolerability of Afrezza in children ages 4 to 17 years with type 1 diabetes mellitus (T1DM). Secondary Objectives: * To assess the ability to titrate the prandial and supplemental doses of Afrezza at each meal. * To assess pharmacokinetics (PK) following a prandial dose of Afrezza in children ages 4 to 17 years with T1DM.

Type 1 Diabetes Mellitus

Mannkind Corporation30 participantsStarted Sep 2017

Los Angeles, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +10 more locations

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

Find Trials by Condition in Philadelphia

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

TSA Versus RSA in Patients >75

Effectiveness of Physical Therapy Interventions for Low Back Pain Targeting the Low Back Only or Low Back Plus Hips

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

GLORIA-AF Registry Program - Second and Third Phases

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

The Diet Gout Trial

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children